Companies
-
Will world-first PBS listing blow BMS’ budget?
- Mon Aug 10
Uptake of BMS’s checkpoint inhibitors soared in the months since the door to broad PBS access opened. Will its success make it unsustainable?
Read more -
Henderson steps up to lead Takeda Oceania
- Mon Aug 10
As flagged by MedNews in June, David Henderson is taking on the Takeda Oceania Country Head role as Dave Pearce prepares to leave the company.
Read more -
Novavax wins court case against Health Secretary
- Fri Aug 7
Sets aside refusal of import application after the Department admits it made an ‘error of law’, the Court ordering the TGA to review it again.
Read more -
Former J&J leader gets Country Manager gig
- Fri Aug 7
The latest changes across Australia’s pharma, medtech and health communications sectors as leaders shuffle companies and roles.
Read more -
argenx expands Monash muscle partnership
- Fri Aug 7
argenx signs a new partnership with Monash University and Myostellar to advance first‑in‑class muscular therapies.
Read more -
Lilly won’t weight in push for obesity market
- Wed Aug 5
Lilly has gone all out with its latest disease awareness campaign with a major investment in prime time television placements.
Read more -
Butler boosts PBS investment with August additions
- Mon Aug 3
With pressure building to fund the PBS, Mark Butler secured over $100 million to pay for new therapies – offset by some significant savings from LOEs.
Read more -
AbbVie calls out PBAC’s ‘pragmatic approach’
- Mon Aug 3
Seeking PBS access for an important new option for patients with a devastating condition, AbbVie was disappointed with the PBAC’s ‘pragmatic approach’.
Read more